Oncology Market Leaders Maintain Their Upper Hand

 
• By Jessica Merrill

Drugs like Ibrance and Lynparza show that in the cancer market, it can be hard for new entrants to catch early standouts. 

competitive edge and business difference concept, many grey balls and one green sphere onto a white background with movement effect and blur. - Illustration
Later entrants in several cancer classes have failed to catch the leader

More from Anticancer

More from Therapy Areas